{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:38:16Z","timestamp":1781217496841,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s11920-008-0052-z","type":"journal-article","created":{"date-parts":[[2008,10,15]],"date-time":"2008-10-15T16:06:56Z","timestamp":1224086816000},"page":"323-330","source":"Crossref","is-referenced-by-count":46,"title":["Emerging treatments for Tourette\u2019s disorder"],"prefix":"10.1007","volume":"10","author":[{"given":"Michael H.","family":"Bloch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,10,16]]},"reference":[{"key":"52_CR1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/anxi.3070010504","volume":"1","author":"J.F. Leckman","year":"1994","unstructured":"Leckman JF, Grice DE, Barr LC, et al.: Tic-related vs. nontic-related obsessive compulsive disorder. Anxiety 1994, 1:208\u2013215.","journal-title":"Anxiety"},{"key":"52_CR2","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.biopsych.2006.09.035","volume":"61","author":"J.S. March","year":"2007","unstructured":"March JS, Franklin ME, Leonard H, et al.: Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry 2007, 61:344\u2013347.","journal-title":"Biol Psychiatry"},{"key":"52_CR3","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/sj.mp.4001823","volume":"11","author":"M.H. Bloch","year":"2006","unstructured":"Bloch MH, Landeros-Weisenberger A, Kelmendi B, et al.: A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 2006, 11:622\u2013632.","journal-title":"Mol Psychiatry"},{"key":"52_CR4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nurx.2006.01.009","volume":"3","author":"L. Scahill","year":"2006","unstructured":"Scahill L, Erenberg G, Berlin CM Jr, et al.: Contemporary assessment and pharmacotherapy of Tourette syndrome. NeuroRx 2006, 3:192\u2013206.","journal-title":"NeuroRx"},{"key":"52_CR5","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/ajp.154.8.1057","volume":"154","author":"F.R. Sallee","year":"1997","unstructured":"Sallee FR, Nesbitt L, Jackson C, et al.: Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette\u2019s disorder. Am J Psychiatry 1997, 154:1057\u20131062.","journal-title":"Am J Psychiatry"},{"key":"52_CR6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1176\/ajp.135.5.585","volume":"135","author":"M.S. Ross","year":"1978","unstructured":"Ross MS, Moldofsky H: A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette\u2019s syndrome. Am J Psychiatry 1978, 135:585\u2013587.","journal-title":"Am J Psychiatry"},{"key":"52_CR7","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/archpsyc.1989.01810080052006","volume":"46","author":"E. Shapiro","year":"1989","unstructured":"Shapiro E, Shapiro AK, Fulop G, et al.: Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette\u2019s syndrome. Arch Gen Psychiatry 1989, 46:722\u2013730.","journal-title":"Arch Gen Psychiatry"},{"key":"52_CR8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00004583-198403000-00007","volume":"23","author":"A.K. Shapiro","year":"1984","unstructured":"Shapiro AK, Shapiro E: Controlled study of pimozide vs. placebo in Tourette\u2019s syndrome. J Am Acad Child Psychiatry 1984, 23:161\u2013173.","journal-title":"J Am Acad Child Psychiatry"},{"key":"52_CR9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000120222","volume":"12","author":"H.S. Singer","year":"1985","unstructured":"Singer HS, Gammon K, Quaskey S: Haloperidol, fluphenazine and clonidine in Tourette syndrome: controversies in treatment. Pediatr Neurosci 1985, 12:71\u201374.","journal-title":"Pediatr Neurosci"},{"key":"52_CR10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/archneur.1984.04050150049015","volume":"41","author":"C.G. Goetz","year":"1984","unstructured":"Goetz CG, Tanner CM, Klawans HL: Fluphenazine and multifocal tic disorders. Arch Neurol 1984, 41:271\u2013272.","journal-title":"Arch Neurol"},{"key":"52_CR11","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","volume":"328","author":"D. Atkins","year":"2004","unstructured":"Atkins D, Best D, Briss PA, et al.: Grading quality of evidence and strength of recommendations. BMJ 2004, 328:1490.","journal-title":"BMJ"},{"key":"52_CR12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1176\/ajp.136.3.317","volume":"136","author":"E.D. Caine","year":"1979","unstructured":"Caine ED, Polinsky RJ, Kartzinel R, Ebert MH: The trial use of clozapine for abnormal involuntary movement disorders. Am J Psychiatry 1979, 136:317\u2013320.","journal-title":"Am J Psychiatry"},{"key":"52_CR13","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1212\/01.WNL.0000055434.39968.67","volume":"60","author":"L. Scahill","year":"2003","unstructured":"Scahill L, Leckman JF, Schultz RT, et al.: A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 2003, 60:1130\u20131135.","journal-title":"Neurology"},{"key":"52_CR14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00004714-200202000-00006","volume":"22","author":"Y. Dion","year":"2002","unstructured":"Dion Y, Annable L, Sandor P, Chouinard G: Risperidone in the treatment of Tourette syndrome: a double-blind, placebo-controlled trial. J Clin Psychopharmacol 2002, 22:31\u201339.","journal-title":"J Clin Psychopharmacol"},{"key":"52_CR15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4088\/JCP.v62n0111","volume":"62","author":"R. Bruggeman","year":"2001","unstructured":"Bruggeman R, van der Linden C, Buitelaar JK, et al.: Risperidone versus pimozide in Tourette\u2019s disorder: a comparative double-blind parallel-group study. J Clin Psychiatry 2001, 62:50\u201356.","journal-title":"J Clin Psychiatry"},{"key":"52_CR16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00004583-200203000-00013","volume":"41","author":"G.R. Gaffney","year":"2002","unstructured":"Gaffney GR, Perry PJ, Lund BC, et al.: Risperidone versus clonidine in the treatment of children and adolescents with Tourette\u2019s syndrome. J Am Acad Child Adolesc Psychiatry 2002, 41:330\u2013336.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"52_CR17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00004583-200003000-00010","volume":"39","author":"F.R. Sallee","year":"2000","unstructured":"Sallee FR, Kurlan R, Goetz CG, et al.: Ziprasidone treatment of children and adolescents with Tourette\u2019s syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry 2000, 39:292\u2013299.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"52_CR18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4088\/JCP.v62n0412","volume":"62","author":"C.L. Budman","year":"2001","unstructured":"Budman CL, Gayer A, Lesser M, et al.: An open-label study of the treatment efficacy of olanzapine for Tourette\u2019s disorder. J Clin Psychiatry 2001, 62:290\u2013294.","journal-title":"J Clin Psychiatry"},{"key":"52_CR19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00004850-200015010-00003","volume":"15","author":"M. Stamenkovic","year":"2000","unstructured":"Stamenkovic M, Schindler SD, Aschauer HN, et al.: Effective open-label treatment of Tourette\u2019s disorder with olanzapine. Int Clin Psychopharmacol 2000, 15:23\u201328.","journal-title":"Int Clin Psychopharmacol"},{"key":"52_CR20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/104454603322572624","volume":"13","author":"N.M. Mukaddes","year":"2003","unstructured":"Mukaddes NM, Abali O: Quetiapine treatment of children and adolescents with Tourette\u2019s disorder. J Child Adolesc Psychopharmacol 2003, 13:295\u2013299.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"52_CR21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/01.jcp.0000150229.69124.66","volume":"25","author":"A. Kastrup","year":"2005","unstructured":"Kastrup A, Schlotter W, Plewnia C, Bartels M: Treatment of tics in Tourette syndrome with aripiprazole. J Clin Psychopharmacol 2005, 25:94\u201396.","journal-title":"J Clin Psychopharmacol"},{"key":"52_CR22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00449911","volume":"237","author":"C. Eggers","year":"1988","unstructured":"Eggers C, Rothenberger A, Berghaus U: Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride. Eur Arch Psychiatry Neurol Sci 1988, 237:223\u2013229.","journal-title":"Eur Arch Psychiatry Neurol Sci"},{"key":"52_CR23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00002826-199006000-00005","volume":"13","author":"M.M. Robertson","year":"1990","unstructured":"Robertson MM, Schnieden V, Lees AJ: Management of Gilles de la Tourette syndrome using sulpiride. Clin Neuropharmacol 1990, 13:229\u2013235.","journal-title":"Clin Neuropharmacol"},{"key":"52_CR24","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1345\/aph.1D497","volume":"38","author":"K.N. Fountoulakis","year":"2004","unstructured":"Fountoulakis KN, Iacovides A, St Kaprinis G: Successful treatment of Tourette\u2019s disorder with amisulpride. Ann Pharmacother 2004, 38:901.","journal-title":"Ann Pharmacother"},{"key":"52_CR25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1212\/WNL.58.4.527","volume":"58","author":"Tourette\u2019s Syndrome Study Group","year":"2002","unstructured":"Tourette\u2019s Syndrome Study Group: Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 2002, 58:527\u2013536.","journal-title":"Neurology"},{"key":"52_CR26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00002826-200211000-00009","volume":"25","author":"D.D. Cummings","year":"2002","unstructured":"Cummings DD, Singer HS, Krieger M, et al.: Neuropsychiatric effects of guanfacine in children with mild Tourette syndrome: a pilot study. Clin Neuropharmacol 2002, 25:325\u2013332.","journal-title":"Clin Neuropharmacol"},{"key":"52_CR27","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1176\/appi.ajp.158.7.1067","volume":"158","author":"L. Scahill","year":"2001","unstructured":"Scahill L, Chappell PB, Kim YS, et al.: A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 2001, 158:1067\u20131074.","journal-title":"Am J Psychiatry"},{"key":"52_CR28","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1176\/appi.ajp.160.6.1175","volume":"160","author":"S. Wilhelm","year":"2003","unstructured":"Wilhelm S, Deckersbach T, Coffey BJ, et al.: Habit reversal versus supportive psychotherapy for Tourette\u2019s disorder: a randomized controlled trial. Am J Psychiatry 2003, 160:1175\u20131177.","journal-title":"Am J Psychiatry"},{"key":"52_CR29","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.brat.2005.08.007","volume":"44","author":"T. Deckersbach","year":"2006","unstructured":"Deckersbach T, Rauch S, Buhlmann U, Wilhelm S: Habit reversal versus supportive psychotherapy in Tourette\u2019s disorder: a randomized controlled trial and predictors of treatment response. Behav Res Ther 2006, 44:1079\u20131090.","journal-title":"Behav Res Ther"},{"key":"52_CR30","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1177\/08830738060210080101","volume":"21","author":"M.B. Himle","year":"2006","unstructured":"Himle MB, Woods DW, Piacentini JC, Walkup JT: Brief review of habit reversal training for Tourette syndrome. J Child Neurol 2006, 21:719\u2013725.","journal-title":"J Child Neurol"},{"key":"52_CR31","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1212\/WNL.56.5.605","volume":"56","author":"C. Marras","year":"2001","unstructured":"Marras C, Andrews D, Sime E, Lang AE: Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology 2001, 56:605\u2013610.","journal-title":"Neurology"},{"key":"52_CR32","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s10072-003-0201-4","volume":"24","author":"M. Porta","year":"2004","unstructured":"Porta M, Maggioni G, Ottaviani F, Schindler A: Treatment of phonic tics in patients with Tourette\u2019s syndrome using botulinum toxin type A. Neurol Sci 2004, 24:420\u2013423.","journal-title":"Neurol Sci"},{"key":"52_CR33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/jnnp.2006.104067","volume":"79","author":"D. Servello","year":"2008","unstructured":"Servello D, Porta M, Sassi M, et al.: Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation. J Neurol Neurosurg Psychiatry 2008, 79:136\u2013142.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"52_CR34","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3171\/JNS-07\/11\/1004","volume":"107","author":"R.J. Maciunas","year":"2007","unstructured":"Maciunas RJ, Maddux BN, Riley DE, et al.: Prospective randomized double-blind trial of bilateral thalamic deep brain stimulation in adults with Tourette syndrome. J Neurosurg 2007, 107:1004\u20131014.","journal-title":"J Neurosurg"},{"key":"52_CR35","first-page":"1891","volume":"21","author":"J.W. Mink","year":"2006","unstructured":"Mink JW, Walkup JT, Frey KA, et al.: Recommended guidelines for deep brain stimulations in Tourette syndrome. Mov Disord 2006, 21:1891\u20131898.","journal-title":"Mov Disord"},{"key":"52_CR36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1017\/S1461145705005729","volume":"9","author":"A. Mantovani","year":"2006","unstructured":"Mantovani A, Lisanby SH, Pieraccini F, et al.: Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette\u2019s syndrome (TS). Int J Neuropsychopharmacol 2006, 9:95\u2013100.","journal-title":"Int J Neuropsychopharmacol"},{"key":"52_CR37","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.clinph.2007.07.011","volume":"118","author":"A. Mantovani","year":"2007","unstructured":"Mantovani A, Leckman JF, Grantz H, et al.: Repetitive transcranial magnetic stimulation of the supplementary motor area in the treatment of Tourette syndrome: report of two cases. Clin Neurophysiol 2007, 118:2314\u20132315.","journal-title":"Clin Neurophysiol"},{"key":"52_CR38","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.yct.0000184618.00661.72","volume":"21","author":"D. Karadenizli","year":"2005","unstructured":"Karadenizli D, Dilbaz N, Bayam G: Gilles de la Tourette syndrome: response to electroconvulsive therapy. J ECT 2005, 21:246\u2013248.","journal-title":"J ECT"},{"key":"52_CR39","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00006842-199807000-00022","volume":"60","author":"M. Rapoport","year":"1998","unstructured":"Rapoport M, Feder V, Sandor P: Response of major depression and Tourette\u2019s syndrome to ECT: a case report. Psychosom Med 1998, 60:528\u2013529.","journal-title":"Psychosom Med"},{"key":"52_CR40","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1080\/15622970410029930","volume":"5","author":"M. Strassnig","year":"2004","unstructured":"Strassnig M, Riedel M, Muller N: Electroconvulsive therapy in a patient with Tourette\u2019s syndrome and co-morbid obsessive compulsive disorder. World J Biol Psychiatry 2004, 5:164\u2013166.","journal-title":"World J Biol Psychiatry"},{"key":"52_CR41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00124509-200306000-00011","volume":"19","author":"H.K. Trivedi","year":"2003","unstructured":"Trivedi HK, Mendelowitz AJ, Fink M: Gilles de la Tourette form of catatonia: response to ECT. J ECT 2003, 19:115\u2013117.","journal-title":"J ECT"},{"key":"52_CR42","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/mds.870120320","volume":"12","author":"J.F. Lipinski","year":"1997","unstructured":"Lipinski JF, Sallee FR, Jackson C, Sethuraman G: Dopamine agonist treatment of Tourette disorder in children: results of an open-label trial of pergolide. Mov Disord 1997, 12:402\u2013407.","journal-title":"Mov Disord"},{"key":"52_CR43","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1212\/WNL.54.6.1310","volume":"54","author":"D.L. Gilbert","year":"2000","unstructured":"Gilbert DL, Sethuraman G, Sine L, et al.: Tourette\u2019s syndrome improvement with pergolide in a randomized, double-blind, crossover trial. Neurology 2000, 54:1310\u20131315.","journal-title":"Neurology"},{"key":"52_CR44","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1212\/01.WNL.0000044058.64647.7E","volume":"60","author":"D.L. Gilbert","year":"2003","unstructured":"Gilbert DL, Dure L, Sethuraman G, et al.: Tic reduction with pergolide in a randomized controlled trial in children. Neurology 2003, 60:606\u2013611.","journal-title":"Neurology"},{"key":"52_CR45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1212\/WNL.48.2.358","volume":"48","author":"J. Jankovic","year":"1997","unstructured":"Jankovic J, Beach J: Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology 1997, 48:358\u2013362.","journal-title":"Neurology"},{"key":"52_CR46","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1212\/WNL.38.3.391","volume":"38","author":"J. Jankovic","year":"1988","unstructured":"Jankovic J, Orman J: Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias. Neurology 1988, 38:391\u2013394.","journal-title":"Neurology"},{"key":"52_CR47","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1017\/S0317167100025129","volume":"4","author":"M. Gonce","year":"1977","unstructured":"Gonce M, Barbeau A: Seven cases of Gilles de la Tourette\u2019s syndrome: partial relief with clonazepam: a pilot study. Can J Neurol Sci 1977, 4:279\u2013283.","journal-title":"Can J Neurol Sci"},{"key":"52_CR48","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00004583-199403000-00014","volume":"33","author":"R.J. Steingard","year":"1994","unstructured":"Steingard RJ, Goldberg M, Lee D, DeMaso DR: Adjunctive clonazepam treatment of tic symptoms in children with comorbid tic disorders and ADHD. J Am Acad Child Adolesc Psychiatry 1994, 33:394\u2013399.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"52_CR49","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1176\/appi.ajp.2007.07060978","volume":"164","author":"M. Bortolato","year":"2007","unstructured":"Bortolato M, Muroni A, Marrosu F: Treatment of Tourette\u2019s syndrome with finasteride. Am J Psychiatry 2007, 164:1914\u20131915.","journal-title":"Am J Psychiatry"},{"key":"52_CR50","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1176\/appi.ajp.158.6.968","volume":"158","author":"F.S. Abuzzahab","year":"2001","unstructured":"Abuzzahab FS, Brown VL: Control of Tourette\u2019s syndrome with topiramate. Am J Psychiatry 2001, 158:968.","journal-title":"Am J Psychiatry"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-008-0052-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11920-008-0052-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-008-0052-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T19:39:32Z","timestamp":1709321972000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11920-008-0052-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["52"],"URL":"https:\/\/doi.org\/10.1007\/s11920-008-0052-z","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}